BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025

BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025 GlobeNewswire October 27, 2025 MAINZ, Germany, October 27, 2025 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the third quarter 2025 on Monday, November 3, 2025. Additionally, the Company will host […]

MoonLake Immunotherapeutics Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – MLTX

MoonLake Immunotherapeutics Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – MLTX GlobeNewswire October 27, 2025 LOS ANGELES, Oct. 27, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against MoonLake Immunotherapeutics (“MoonLake” or “the Company”) (NASDAQ: MLTX) for violations of §§10(b)

BexBack Launches Crypto Futures Trading with Up to 100x Leverage, No KYC Access and $100 Welcome Bonus

BexBack Launches Crypto Futures Trading with Up to 100x Leverage, No KYC Access and $100 Welcome Bonus GlobeNewswire October 27, 2025 Singapore, Oct. 27, 2025 (GLOBE NEWSWIRE) — BexBack, a global cryptocurrency derivatives platform, today announced the launch of its enhanced crypto futures trading service, offering High-Leverage Trading and simplified onboarding. With Bitcoin's price fluctuating

Recover Investment Losses: Class Action Initiated Against Baxter International, Inc. (BAX)

NEW YORK, NY / ACCESS Newswire / October 27, 2025 / If you suffered a loss on your Baxter International, Inc. (NYSE:BAX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/baxter-international-inc-lawsuit-submission-form?prid=174065&wire=1&utm_campaign=24 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

MLTX INVESTOR NOTICE: MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

Robbins Geller Rudman & Dowd LLP announces that the MoonLake class action lawsuit – captioned Peters v. MoonLake Immunotherapeutics, No. 25-cv-08612, and pending in the Southern District of New York – seeks to represent purchasers or acquirers of MoonLake Immunotherapeutics (NASDAQ: MLTX) common stock and charges MoonLake as well as certain of MoonLake's top executives

LIFE AI Joins First Ever FastTrack AI Accelerator Powered By GenAI Fund and NVIDIA Inception Program

SINGAPORE, Oct. 27, 2025 (GLOBE NEWSWIRE) — In a monumental selection, LIFE AI has been chosen to join the first-ever FastTrack AI Accelerator, Cohort 1 – a program powered by GenAI Fund and accelerated by NVIDIA – designed to fast-track the most promising AI startups toward enterprise adoption, scalable impact, and investment readiness. The inclusion

Lennox International Inc. Investigated Regarding Potential Securities Law Violations – Contact Levi & Korsinsky for Details – LII

NEW YORK, NY / ACCESS Newswire / October 27, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Lennox International Inc. ("Lennox International Inc.") (NYSE:LII) concerning possible violations of federal securities laws. On October 22, 2025, Lennox published mixed third quarter 2025 financial results. Particularly, the Company disclosed that it

EINC to Divest Two U.S. Auction Sites

Company to Focus on Licensing Technology and Canadian Growth E Automotive Inc. (“EINC” or the “Company”), a leader in automotive wholesale solutions offered under the brands EBlock, EDealer and Cars.ca, today announces the divestment of certain non-core US assets including its New Orleans and Houston physical auctions by way of an asset purchase agreement between

Scroll to Top